Bacil Pharma Limited (BOM:524516)
India
· Delayed Price · Currency is INR 50.00
+0.05 (0.10%)
At close: Mar 9, 2026
Bacil Pharma Revenue
Bacil Pharma had revenue of 645.00K INR in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 5.48M.
Revenue (ttm)
5.48M
Revenue Growth
n/a
P/S Ratio
130.98
Revenue / Employee
2.74M
Employees
2
Market Cap
717.65M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tyche Industries | 505.54M |
| Resonance Specialties | 899.72M |
| Krebs Biochemicals & Industries | 230.23M |
| Accretion Nutraveda | 160.49M |
| Vasundhara Rasayans | 315.86M |
| Panchsheel Organics | 1.03B |
| Smruthi Organics | 1.11B |
| Kimia Biosciences | 1.26B |